This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
DDX27 Polyclonal Antibody
catalog :
PA5-41281
quantity :
100 uL
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
Product Type :
Antibody
Product Name :
DDX27 Polyclonal Antibody
Catalog # :
PA5-41281
Quantity :
100 uL
Price :
US 464.00
Clonality :
Polyclonal
Purity :
protein A
Host :
Rabbit
Reactivity :
Human
Applications :
Western Blot: 0.625 ug/mL
Species :
Human
Isotype :
IgG
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
La is involved in diverse aspects of RNA metabolism, including binding and protecting 3-prime UUU(OH) elements of newly RNA polymerase III.
Immunogen :
Synthetic peptide directed towards the N-terminal of human DDX27 (aa 118-167).
Format :
Liquid
Applications w/Dilutions :
Western Blot: 0.625 ug/mL
Aliases :
C86129; cPERP-F; Ddx27; DEAD (Asp-Glu-Ala-Asp) box polypeptide 27; DEAD box protein 27; DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 27; DEAD-box helicase 27; Deficiency of ribosomal subunits protein 1 homolog; dJ686N3.1; DRS1; Drs1p; HSPC259; LOW QUALITY PROTEIN: probable ATP-dependent RNA helicase DDX27; PP3241; Probable ATP-dependent RNA helicase DDX27; probable ATP-dependent RNA helicase DDX27-like; RHLP; RNA helicase-like protein; RNA-helicase like protein; Rrp3p
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments